Neurofilament light chain as a biomarker for diagnosis of multiple sclerosis

The treatments for multiple sclerosis (MS) have improved over the past 25 years, but now the main question for physicians is deciding who should receive treatment, for how long, and when to switch to other options. These decisions are typically based on treatment tolerance and a reasonable expectati...

Descripción completa

Detalles Bibliográficos
Autores principales: Kouchaki, Ebrahim, Dashti, Fatemeh, Mirazimi, Seyed Mohammad Ali, Alirezaei, Zahra, Jafari, Seyed Hamed, Hamblin, Michael R., Mirzaei, Hamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Leibniz Research Centre for Working Environment and Human Factors 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481790/
https://www.ncbi.nlm.nih.gov/pubmed/34602928
http://dx.doi.org/10.17179/excli2021-3973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481790/
https://www.ncbi.nlm.nih.gov/pubmed/34602928
http://dx.doi.org/10.17179/excli2021-3973

Ejemplares similares